# | Year | Title | Cited |
---|
1 | 2008 | Conducting Discrete Choice Experiments to Inform Healthcare Decision Making. (2008). Lancsar, Emily ; Louviere, Jordan. In: PharmacoEconomics. RePEc:spr:pharme:v:26:y:2008:i:8:p:661-677. | 57 |
2 | 2013 | Consolidated Health Economic Evaluation Reporting Standards (CHEERS) Statement. (2013). Husereau, Don ; Briggs, Andrew ; Petrou, Stavros ; Drummond, Michael ; Mauskopf, Josephine ; Augustovski, Federico ; Loder, Elizabeth ; Moher, David ; Greenberg, Dan ; Carswell, Chris . In: PharmacoEconomics. RePEc:spr:pharme:v:31:y:2013:i:5:p:361-367. | 40 |
3 | 2017 | Discrete Choice Experiments: A Guide to Model Specification, Estimation and Software. (2017). Lancsar, Emily ; Hole, Arne ; Fiebig, Denzil. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:7:d:10.1007_s40273-017-0506-4. | 34 |
4 | 2019 | Discrete Choice Experiments in Health Economics: Past, Present and Future. (2019). Soekhai, Vikas ; Vass, Caroline M ; Ellis, Alan R ; Bekker-Grob, Esther W. In: PharmacoEconomics. RePEc:spr:pharme:v:37:y:2019:i:2:d:10.1007_s40273-018-0734-2. | 25 |
5 | 2014 | Discrete Choice Experiments in Health Economics: A Review of the Literature. (2014). Moro, Domenico ; Petrou, Stavros ; Clark, Michael ; Bekker-Grob, Esther ; Determann, Domino . In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:9:p:883-902. | 24 |
6 | 2014 | A Guide to Handling Missing Data in Cost-Effectiveness Analysis Conducted Within Randomised Controlled Trials. (2014). White, Ian ; Gomes, Manuel ; Faria, Rita ; EPSTEIN, DAVID. In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:12:p:1157-1170. | 14 |
7 | 2014 | Reconceptualising the External Validity of Discrete Choice Experiments. (2014). Swait, Joffre ; Lancsar, Emily. In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:10:p:951-965. | 13 |
8 | 2016 | Health, Health-Related Quality of Life, and Quality of Life: What is the Difference?. (2016). Brazier, John ; Karimi, Milad. In: PharmacoEconomics. RePEc:spr:pharme:v:34:y:2016:i:7:d:10.1007_s40273-016-0389-9. | 11 |
9 | 2015 | A Review of the Development and Application of Generic Multi-Attribute Utility Instruments for Paediatric Populations. (2015). Chen, Gang ; Ratcliffe, Julie. In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:10:p:1013-1028. | 10 |
10 | 2014 | Managing short-term capital flows in new central banking: unconventional monetary policy framework in Turkey. (2014). Aysan, Ahmet ; Fendoglu, Salih ; Kilinc, Mustafa . In: PharmacoEconomics. RePEc:spr:pharme:v:4:y:2014:i:1:p:45-69. | 10 |
11 | 2014 | Preferences for Oral Anticoagulants in Atrial Fibrillation: a Bestââ¬âBest Discrete Choice Experiment. (2014). Lancsar, Emily ; Ghijben, Peter ; Zavarsek, Silva . In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:11:p:1115-1127. | 10 |
12 | 2013 | How to Include Informal Care in Economic Evaluations. (2013). van Exel, Job ; Brouwer, Werner ; Hoefman, Renske . In: PharmacoEconomics. RePEc:spr:pharme:v:31:y:2013:i:12:p:1105-1119. | 9 |
13 | 2014 | How to Estimate Productivity Costs in Economic Evaluations. (2014). Brouwer, Werner ; Krol, Marieke . In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:4:p:335-344. | 9 |
14 | 2017 | International Regulations and Recommendations for Utility Data for Health Technology Assessment. (2017). Rowen, Donna ; Hout, Ben ; Chevrou-Severac, Helene ; Zouraq, Ismail Azzabi. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:1:d:10.1007_s40273-017-0544-y. | 9 |
15 | 2015 | Savings in Medical Expenditures Associated with Reductions in Body Mass Index Among US Adults with Obesity, by Diabetes Status. (2015). Cawley, John ; Biener, Adam ; Wintfeld, Neil ; Meyerhoefer, Chad ; Hammer, Mette . In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:7:p:707-722. | 8 |
16 | 2015 | The Economic Costs of Type 2 Diabetes: A Global Systematic Review. (2015). Seuring, Till ; Suhrcke, Marc ; Archangelidi, Olga . In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:8:p:811-831. | 8 |
17 | 2018 | German Value Set for the EQ-5D-5L. (2018). Ludwig, Kristina ; Greiner, Wolfgang ; von der Schulenburg, J-Matthias Graf ; J-Matthias Graf von der Schulenburg, . In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:6:d:10.1007_s40273-018-0615-8. | 7 |
18 | 2015 | A Practical Guide to Value of Information Analysis. (2015). Wilson, Edward . In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:2:p:105-121. | 7 |
19 | 2011 | Effects of Reference Pricing in Pharmaceutical Markets. (2011). Miraldo, Marisa ; Galizzi, Matteo ; Ghislandi, Simone. In: PharmacoEconomics. RePEc:spr:pharme:v:29:y:2011:i:1:p:17-33. | 7 |
20 | 2016 | EuroQol Protocols for Time Trade-Off Valuation of Health Outcomes. (2016). Shah, Koonal ; Luo, Nan ; Ramosgoi, Juan M ; Rand-Hendriksen, Kim ; Oppe, Mark. In: PharmacoEconomics. RePEc:spr:pharme:v:34:y:2016:i:10:d:10.1007_s40273-016-0404-1. | 7 |
21 | 2014 | Capitalââ¬â¢s grabbing hand? A cross-industry analysis of the decline of the labor share in OECD countries. (2014). Bassanini, Andrea ; Manfredi, Thomas . In: PharmacoEconomics. RePEc:spr:pharme:v:4:y:2014:i:1:p:3-30. | 7 |
22 | 2015 | The Epidemiology of Obesity: A Big Picture. (2015). Hu, Frank ; Hruby, Adela . In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:7:p:673-689. | 6 |
23 | 2014 | Estimating QALY Gains in Applied Studies: A Review of Cost-Utility Analyses Published in 2010. (2014). Movik, Espen ; Hamidi, Vida ; Wisloff, Torbjorn ; Klemp, Marianne ; Olsen, Jan ; Hagen, Gunhild . In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:4:p:367-375. | 6 |
24 | 2016 | Using Bestââ¬âWorst Scaling to Investigate Preferences in Health Care. (2016). Hollin, Ilene L ; Cheung, Kei Long ; Hiligsmann, Mickael ; Silvia, ; Bridges, John F ; Janssen, Ellen M. In: PharmacoEconomics. RePEc:spr:pharme:v:34:y:2016:i:12:d:10.1007_s40273-016-0429-5. | 6 |
25 | 2017 | The Implementation of Managed Entry Agreements in Central and Eastern Europe: Findings and Implications. (2017). Loblova, Olga ; Ferrario, Alessandra ; Kanavos, Panos ; Laidmae, Erki ; Haycox, Alan ; Jakupi, Arianit ; Voncina, Luka ; Hoxha, Iris ; Tomek, Dominik ; Greiit-Kuprijanov, Ieva ; Pomorski, Maciej ; Furst, Jurij ; Petrova, Guenka ; Dimitrova, Maria ; Novakovic, Tanja ; Danko, David ; Meshkov, Dmitry ; Ati, Tarik ; Markovic-Pekovic, Vanda ; Bochenek, Tomasz ; Godman, Brian ; Mardare, Ileana ; Arja, Dina ; Bonanno, Patricia Vella. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:12:d:10.1007_s40273-017-0559-4. | 6 |
27 | 2015 | Disinvestment and Value-Based Purchasing Strategies for Pharmaceuticals: An International Review. (2015). Viney, Rosalie ; Sermet, Catherine ; Parkinson, Bonny ; Elshaug, Adam ; Lopert, Ruth ; Pearson, Sallie-Anne ; Choudhury, Moni ; Garner, Sarah ; Godman, Brian ; Crausaz, Steffan ; Clement, Fiona . In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:9:p:905-924. | 6 |
28 | 2016 | From Good to Better: New Dutch Guidelines for Economic Evaluations in Healthcare. (2016). Brouwer, Werner ; Knies, Saskia ; Versteegh, Matthijs . In: PharmacoEconomics. RePEc:spr:pharme:v:34:y:2016:i:11:d:10.1007_s40273-016-0431-y. | 6 |
29 | 2018 | Discounting in Economic Evaluations. (2018). Claxton, Karl ; Attema, Arthur. In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:7:d:10.1007_s40273-018-0672-z. | 6 |
30 | 2015 | Preferred Reporting Items for Studies Mapping onto Preference-Based Outcome Measures: The MAPS Statement. (2015). Gray, Alastair ; Petrou, Stavros ; Froud, Robert ; Oppe, Mark ; Longworth, Louise ; Dakin, Helen ; Rivero-Arias, Oliver. In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:10:p:985-991. | 5 |
31 | 2013 | Reference Pricing and Price Negotiations for Innovative New Drugs. (2013). Gandjour, Afschin. In: PharmacoEconomics. RePEc:spr:pharme:v:31:y:2013:i:1:p:11-14. | 5 |
32 | 2013 | Overview of Parametric Survival Analysis for Health-Economic Applications. (2013). Kreif, Noemi ; Benedict, Agnes ; Muszbek, Noemi ; Ishak, K.. In: PharmacoEconomics. RePEc:spr:pharme:v:31:y:2013:i:8:p:663-675. | 5 |
33 | 2016 | The Impact of Different DCE-Based Approaches When Anchoring Utility Scores. (2016). Viney, Rosalie ; Mulhern, Brendan ; Norman, Richard. In: PharmacoEconomics. RePEc:spr:pharme:v:34:y:2016:i:8:d:10.1007_s40273-016-0399-7. | 5 |
34 | 2016 | Value-Based Assessment of New Medical Technologies: Towards a Robust Methodological Framework for the Application of Multiple Criteria Decision Analysis in the Context of Health Technology Assessment. (2016). Kanavos, Panos ; Angelis, Aris. In: PharmacoEconomics. RePEc:spr:pharme:v:34:y:2016:i:5:d:10.1007_s40273-015-0370-z. | 5 |
35 | 2018 | Estimating the Reference Incremental Cost-Effectiveness Ratio for the Australian Health System. (2018). Edney, Laura Catherine ; Karnon, Jonathan ; Cheng, Terence Chai ; Ali, Hossein Haji. In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:2:d:10.1007_s40273-017-0585-2. | 5 |
36 | 2018 | Differential Pricing of Pharmaceuticals: Theory, Evidence and Emerging Issues. (2018). Danzon, Patricia. In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:12:d:10.1007_s40273-018-0696-4. | 5 |
37 | 2015 | Costs to Health Services and the Patient of Treating Tuberculosis: A Systematic Literature Review. (2015). Laurence, Yoko ; Vassall, Anna ; Griffiths, Ulla . In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:9:p:939-955. | 5 |
38 | 2018 | Utility Values for Health States in Ireland: A Value Set for the EQ-5D-5L. (2018). Hobbins, Anna ; Oneill, Ciaran ; Ramos, Juan Manuel ; Devlin, Nancy ; Shah, Koonal ; Kelleher, Dan ; Barry, Luke . In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:11:d:10.1007_s40273-018-0690-x. | 4 |
39 | 2011 | Calibrating Models in Economic Evaluation. (2011). Foss, Anna ; Edmunds, W. ; Vanni, Tazio ; Legood, Rosa ; White, Richard ; Karnon, Jonathan ; Madan, Jason . In: PharmacoEconomics. RePEc:spr:pharme:v:29:y:2011:i:1:p:35-49. | 4 |
40 | 2015 | Valuing QALYs in Relation to Equity Considerations Using a Discrete Choice Experiment. (2015). van Exel, Job ; Brouwer, Werner ; Bobinac, Ana ; Wetering, Liesbet . In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:12:p:1289-1300. | 4 |
41 | 2011 | Calibrating Models in Economic Evaluation. (2011). Karnon, Jonathan ; Vanni, Tazio . In: PharmacoEconomics. RePEc:spr:pharme:v:29:y:2011:i:1:p:51-62. | 4 |
42 | 2018 | Estimating Drug Costs: How do Manufacturer Net Prices Compare with Other Common US Price References?. (2018). Mattingly, Joseph T ; Perfetto, Eleanor M ; Onwudiwe, Nneka C ; Slejko, Julia F ; Levy, Joseph F. In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:9:d:10.1007_s40273-018-0667-9. | 4 |
43 | 2015 | Economic Evaluations with Agent-Based Modelling: An Introduction. (2015). He, Tianhua ; Chhatwal, Jagpreet . In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:5:p:423-433. | 4 |
44 | 2017 | Does the Public Prefer Health Gain for Cancer Patients? A Systematic Review of Public Views on Cancer and its Characteristics. (2017). Morrell, Liz ; Barker, Richard ; Rees, Sian ; Wordsworth, Sarah . In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:8:d:10.1007_s40273-017-0511-7. | 4 |
45 | 2018 | A Systematic Review of Studies Comparing the Measurement Properties of the Three-Level and Five-Level Versions of the EQ-5D. (2018). Buchholz, Ines ; Feng, You-Shan ; Kohlmann, Thomas ; Janssen, Mathieu F. In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:6:d:10.1007_s40273-018-0642-5. | 4 |
46 | 2014 | Innovation for economic performance: the case of Latin American firms. (2014). Arias-Ortiz, Elena ; Zuiga, Pluvia ; Crespi, Gustavo ; Vargas, Fernando ; Tacsir, Ezequiel. In: PharmacoEconomics. RePEc:spr:pharme:v:4:y:2014:i:1:p:31-50. | 4 |
47 | 2015 | Does Including Informal Care in Economic Evaluations Matter? A Systematic Review of Inclusion and Impact of Informal Care in Cost-Effectiveness Studies. (2015). van Exel, Job ; Krol, Marieke ; Papenburg, Joce . In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:2:p:123-135. | 4 |
48 | 2018 | Is EQ-5D-5L Better Than EQ-5D-3L? A Head-to-Head Comparison of Descriptive Systems and Value Sets from Seven Countries. (2018). Janssen, Mathieu F ; Luo, Nan ; Bonsel, Gouke J. In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:6:d:10.1007_s40273-018-0623-8. | 4 |
49 | 2019 | Cost-Effectiveness of Herpes Zoster Vaccination: A Systematic Review. (2019). Chiyaka, Edward T ; Le, Phuc ; Mullen, Patricia Dolan ; Deshpande, Abhishek ; Zhang, LU ; Nghiem, Van T. In: PharmacoEconomics. RePEc:spr:pharme:v:37:y:2019:i:2:d:10.1007_s40273-018-0735-1. | 4 |
50 | 2013 | Decision-Makersââ¬â¢ Preferences for Approving New Medicines in Wales: A Discrete-Choice Experiment with Assessment of External Validity. (2013). Hughes, Dyfrig ; Linley, Warren . In: PharmacoEconomics. RePEc:spr:pharme:v:31:y:2013:i:4:p:345-355. | 4 |